Aclimostat Uses, Dosage, Side Effects and more
Aclimostat is under investigation in clinical trial NCT03254368 (Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes).
| Attribute | Details |
|---|---|
| Trade Name | Aclimostat |
| Generic | Aclimostat |
| Aclimostat Other Names | Aclimostat |
| Type | |
| Formula | C26H42N2O6 |
| Weight | Average: 478.63 Monoisotopic: 478.30428708 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
